You are here

Clinical Trials: Myocardial Ischemia

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Monday, March 12, 2018 - 12:00
Condition:   Acute Myocardial Infarction
Intervention:   Biological: Allogeneic umbilical cord mesenchymal stem cells
Sponsor:   Ever Supreme Bio Technology Co., Ltd.
Not yet recruiting
Posted: Wednesday, March 7, 2018 - 12:00
Conditions:   Refractory Angina;   Chronic Myocardial Ischemia
Interventions:   Device: CardiAMP Cell Therapy System;   Other: Sham Treatment
Sponsor:   BioCardia, Inc.
Not yet recruiting
Posted: Friday, January 19, 2018 - 12:00
Condition:   Myocardial Infarction
Interventions:   Drug: Cardiac Drug;   Drug: Placebos
Sponsors:   John Paul II Hospital, Krakow;   KCRI;   National Center for Research and Development, Poland
Recruiting
Posted: Thursday, January 11, 2018 - 12:00
Condition:   Ischemic Heart Disease
Interventions:   Combination Product: CSWT+BMMSCs;   Device: CSWT+Sham operation
Sponsor:   Shanghai 10th People's Hospital
Recruiting
Posted: Wednesday, November 22, 2017 - 12:00
Conditions:   Chronic Heart Failure;   Old Myocardial Infarction
Intervention:   Biological: Stem cells administered to participants
Sponsors:   Sakakibara Heart Institute;   CellBank of Japan
Not yet recruiting
Posted: Tuesday, July 4, 2017 - 12:00
Conditions:   Coronary Heart Disease;   Angina Pectoris;   Myocardial Infarction
Interventions:   Device: COMBO;   Device: ORSIRO
Sponsors:   Aarhus University Hospital Skejby;   Biotronik SE & Co. KG;   OrbusNeich
Recruiting - verified July 2017
Posted: Tuesday, May 2, 2017 - 12:00
Conditions:   Myocardial Infarction;   Heart Failure
Interventions:   Biological: Intracoronary injection of stem cell;   Biological: Placebo
Sponsor:   SCARM Institute, Tabriz, Iran
Not yet recruiting - verified July 2017
Posted: Sunday, February 12, 2017 - 12:00
Condition:   Quality of Life
Interventions:   Drug: Caduet 10Mg-20Mg Tablet;   Drug: NorvasC® 10 mg Tablets
Sponsor:   Kosin University Gospel Hospital
Not yet recruiting - verified February 2017
Posted: Tuesday, February 7, 2017 - 12:00
Conditions:   Myocardial Infarction;   Stem Cell Transplantation;   Angioplasty, Transluminal, Percutaneous Coronary
Interventions:   Drug: Atorvastatin;   Drug: Intensive Atorvastatin;   Drug: Low dose BMMSC;   Drug: Middle dose BMMSC;   Drug: High dose BMMSC;   Drug: Transplantation
Sponsors:   Yuejin Yang;   Peking Union Medical College Hospital;   The First Hospital of Hebei Medical University;   Zunyi Medical College
Not yet recruiting - verified February 2017
Posted: Wednesday, November 23, 2016 - 12:00
Conditions:   Endothelial Progenitor Cells;   Coronary Artery Disease;   Vascular Injury;   Coronary Angiography
Intervention:   Biological: Administration of radio labelled endothelial outgrowth cells
Sponsors:   University of Edinburgh;   British Heart Foundation
Recruiting - verified October 2016

Pages